DDX3 is a human RNA helicase with plethoric functions. Our previous studies have indicated that DDX3 is a transcriptional regulator and functions as a tumor suppressor. In this study, we use a bicistronic reporter to demonstrate that DDX3 specifically represses cap-dependent translation but enhances hepatitis C virus internal ribosome entry site-mediated translation in vivo in a helicase activity-independent manner. To elucidate how DDX3 modulates translation, we identified translation initiation factor eukaryotic initiation factor 4E (eIF4E) as a DDX3-binding partner. Interestingly, DDX3 utilizes a consensus eIF4E-binding sequence YIPPHLR to interact with the functionally important dorsal surface of eIF4E in a similar manner to other eIF4E-binding proteins. Furthermore, cap affinity chromatography analysis suggests that DDX3 traps eIF4E in a translationally inactive complex by blocking interaction with eIF4G. Point mutations within the consensus eIF4E-binding motif in DDX3 impair its ability to bind eIF4E and result in a loss of DDX3's regulatory effects on translation. All these features together indicate that DDX3 is a new member of the eIF4E inhibitory proteins involved in translation initiation regulation. Most importantly, this DDX3-mediated translation regulation also confers the tumor suppressor function on DDX3. Altogether, this study demonstrates regulatory roles and action mechanisms for DDX3 in translation, cell growth and likely viral replication.
Introduction DDX3, also named as DDX3X, DBX or CAP-Rf, is a human RNA helicase (Park et al., 1998; You et al., 1999) . As a member of DEAD box RNA helicase family, DDX3 is a nucleo-cytoplasmic shuttling protein and possesses RNA-dependent ATPase/helicase activity (You et al., 1999; Yedavalli et al., 2004) . Although the precise biological function of DDX3 remains elusive, it has been reported that DDX3 is involved in many cellular processes. For example, DDX3 has been isolated from the RNA transporting granules, which implies a role in mRNA migration (Kanai et al., 2004) . Additionally, owing to its association with functional spliceosomes, DDX3 has been suggested to be involved in RNA splicing (Zhou et al., 2002) . Most interestingly, DDX3 is not only required for HIV Rev-RRE export (Yedavalli et al., 2004) , but also interacts with hepatitis C virus (HCV) core protein (Mamiya and Worman, 1999; Owsianka and Patel, 1999; You et al., 1999) , suggesting a role in the life cycle or pathogenesis of certain viruses. More recently, we demonstrated that DDX3 harbors tumor-growth suppressive ability and can modulate the transcriptional activity of the p21 waf1/cip1 promoter through physical interaction with Sp1 (Chao et al., 2006) . Furthermore, we have also reported that DDX3 is inactivated through deregulation of expression or nuclear exclusion in tumor cells (Chang et al., 2006; Chao et al., 2006) . These findings suggest a regulatory role for DDX3 in cell growth and tumorigenesis.
Based on sequence homology, DDX3 and its homologues, including Ded1p in yeast and PL10 in mouse, are assigned to the Ded1p subfamily (reviewed by Linder, 2003) . Ded1p is required for translation initiation as suggested by genetic and biochemical analysis (Chuang et al., 1997; de la Cruz et al., 1997) . Although it has been shown that DDX3 can rescue a ded1 deletion mutant in yeast (Mamiya and Worman, 1999) , the exact functional role of DDX3 in translation has not been elaborated.
Regulation of translation plays a central role in the control of gene expression. Under most circumstances, recruitment of ribosomes to mRNA is the rate-limiting step in translation initiation and a primary target for translational control (for reviews, see Gingras et al., 1999) . In mammalian cells, two different mechanisms of translation initiation exist. Specifically, cap-independent translation involves the interaction of ribosomes with an internal ribosomal entry site (IRES) and is utilized by a subset of plus-stranded RNA viruses as well as some cellular transcripts. While in the case of cap-dependent translation, this process represents the standard mode of translation for most cellular mRNAs and translation initiation begins with the recruitment of the 40S ribosomal subunit to the mRNA 5 0 -terminal m 7 GpppN cap structure. This process is facilitated by the capbinding complex known as eIF4F. The eIF4F complex contains the cap-binding protein eukaryotic translation initiation factor 4E (eIF4E) and the adaptor protein eIF4G. Whereas eIF4E directly recognizes the cap structure, eIF4G serves as a scaffold and binds to eIF4E and to the ribosome-associated factor, eIF3; this bridges the mRNA and the ribosome (for current reviews, see Gingras et al., 1999; Gebauer and Hentze, 2004) . The interaction between eIF4E and eIF4G involves a conserved motif with the consensus sequence YxxxxLF (where x is any residue and F is a hydrophobic amino acid) in eIF4G, while binding of eIF4G to eIF4E occurs via the dorsal surface centering around Trp 73 of eIF4E Marcotrigiano et al., 1999) . The interaction between these two motifs is required for translation initiation and therefore its disruption or reinforcement is an important target for translational control. Interestingly, a group of cellular factors generally known as eIF4E inhibitory proteins, including the original three eIF4E-binding proteins (4EBP1, 4EBP2 and 4EBP3) as well as Maskin, Bicoid and Cup, utilize this conserved region to modulate capdependent translation by the prevention of eIF4F complex formation through sequestering the available eIF4E (for current reviews, see Gebauer and Hentze, 2004; von der Haar et al., 2004; Richter and Sonenberg, 2005) . These eIF4E inhibitory proteins play fundamental roles in cell cycle progression, metabolism, development, tumor formation and responses to various stimuli (Gebauer and Hentze, 2004; von der Haar et al., 2004; Richter and Sonenberg, 2005) .
In this study, we present evidence that DDX3 specifically represses cap-dependent translation, but not HCV IRES-mediated translation, in a helicase activityindependent manner. In an effort to elucidate how DDX3 represses translation, we have searched for DDX3-binding proteins. Here, we demonstrate that DDX3 interacts with translation initiation factor eIF4E. Interestingly, DDX3 contains a functional eIF4E-binding motif that is required for the translation inhibitory effect exerted by DDX3. Furthermore, cap affinity chromatography analysis suggests that DDX3 traps eIF4E in a translationally inactive complex that is unable to interact with eIF4G. Taken together, our data indicate that DDX3 is a novel eIF4E inhibitory protein involved in translation initiation regulation. It should also be noted that DDX3 stimulates IRES-mediated translation in vivo. Presumably, this DDX3-mediated stimulatory effect on IRES-dependent translation is through sequestration of the available eIF4E, which may augment HCV viral replication or selectively stimulate IRES-directed translation of cellular transcripts. Most importantly, this eIF4E-binding ability or translation regulatory effect of DDX3 is required for the tumor growth suppressor function of DDX3 that has been reported recently (Chang et al., 2006; Chao et al., 2006) .
Results

DDX3 represses protein synthesis in vivo
To determine the functional role of DDX3 on global protein production, the level of de novo protein synthesis, as reflected by the incorporation of [ 35 S]methionine into acid-precipitable peptides during pulse labeling, was examined following the overexpression of DDX3. As demonstrated in Figure 1a , forced expression of DDX3 in HuH-7 cells inhibited [ 35 S]methionine incorporation efficiency in a dosedependent manner (27-50% reduction). To ensure that the decreased protein production is a result of translation suppression rather than altered mRNA stability or transcription, the abundance of the different transcripts was analysed by quantitative real-time PCR. Interestingly, in contrast to the repression of protein production in DDX3-overexpressing cells (Figure 1a) , the mRNA levels of several cellular genes analysed in DDX3-overexpressing cells were higher than those in control cells (Supplementary Figure 1) . Thus, the DDX3-mediated repression of protein production occurs posttranscriptionally and does not result from a decrease in mRNA transcripts.
To further assess the role of DDX3 in translation, two DDX3 downregulated HeLa stable cell lines siDDX3-433-11 and siDDX3-433-31, together with a control cell line (see Materials and methods), were used for a metabolic labeling experiment. Figure 1b reveals that there is an increase in protein synthesis (about 155-158% of control) in DDX3 downregulated siDDX3-433-11 and siDDX3-433-31 cells compared to the control or parental HeLa cells. Therefore, our results clearly indicate that downregulation of DDX3 enhances protein synthesis, a feature that correlates well with the inhibitory effect of DDX3 on protein synthesis.
DDX3 specifically represses cap-dependent translation but not IRES-mediated translation in vitro and in vivo To further examine the effect of DDX3 on protein synthesis, we performed an in vitro translation assay using a bicistronic reporter. In this bicistronic reporter transcript, the translation of Renilla luciferase (RLuc) is cap-dependent, whereas that of firefly luciferase (FLuc), which is encoded by the same transcript, is directed by the HCV IRES and therefore is cap-independent (Figure 2a ). The capped bicistronic luciferase RNA was translated in the rabbit reticulocyte (RRL) system in the presence of glutathione-S-transferase (GST), GST-DDX3 or GST-4EBP1 purified fusion protein and luciferase activity (both FLuc and RLuc) were measured to reflect the effect of DDX3 on cap-and IRES-dependent translation. As shown in Figure 2a , both cap-and IRES-dependent translations were unaffected by GST (1 mM) (lane 4). Interestingly, addition of GST-4EBP1 (0.1-0.5 mM), a well-characterized cap-dependent translation inhibitor, markedly inhibited the cap-dependent translation in a concentrationdependent manner (26-67% reduction), whereas there was a less significant effect found on the IRES-mediated translation (Figure 2a, lanes 8-10) . In a parallel study, GST-DDX3 exhibited a similar but slightly weaker inhibitory effect on the cap-dependent RLuc translation (22-54% reduction) compared with GST-4EBP1, while essentially having no effect on IRES-mediated translation (Figure 2a, lanes 5-7) . Thus, DDX3 preferentially represses cap-dependent translation in vitro.
Given that DDX3 harbors the trans-acting ability (You et al., 1999; Chao et al., 2006) , we utilized an RNA reporter transfection assay to further investigate whether DDX3 specifically inhibits cap-dependent translation in vivo. To this end, various amounts of FLAG-DDX3 expression plasmid and a fixed amount of bicistronic reporter transcript were sequentially transfected into 293T cells. Our results suggest that, consistent with the in vitro observation (Figure 2a) , FLAG-DDX3 produced a dose-dependent decrease in cap-dependent RLuc translation (42-78% reduction) (Figure 2b ). It should also be noted that FLAG-DDX3 did not suppress the IRES-dependent FLuc translation; instead, there was a slight increase of IRES-mediated translation in DDX3-overexpressing cells (lanes 3 and 4, 121-128%). This suggests that the in vivo inhibitory DDX3 interacts with eIF4E and regulates translation J-W Shih et al effect of DDX3 is specific for cap-dependent translation but not IRES-mediated translation. Since DDX3 harbors ATPase and RNA helicase activities, we further investigated whether these enzymatic activities are required for the DDX3-mediated translational regulation by introducing point mutations into the DEAD box and SAT motif of DDX3. A point mutation of the DEAD motif to DQAD sequence severely impairs ATPase activity and helicase activity, while the conversion of the SAT motif to AAA leads to a loss of the RNA unwinding activity but retains the ATPase activity of the helicase (Tanner and Linder, Relative activity (%) 2001). These generated FLAG-DDX3 DQAD and FLAG-DDX3 AAA mutants showed a comparable inhibitory effect on cap-dependent translation (72-76% inhibition) (Figure 2c , lanes 3 and 4) compared to the wild-type FLAG-DDX3 (lane 2); this suggests that neither of these two enzymatic activities is required for the DDX3-mediated suppressive effect on cap-dependent translation. It should also be noted that, in a manner similar to the wild-type DDX3, both mutants activated IRESmediated translation by nearly twofold, indicating that DDX3 may differentially regulate the in vivo cap-and IRES-dependent translation in a helicase-and ATPaseindependent manner.
To further elucidate the regulatory role of DDX3 in translation, we performed the same bicistronic RNA transfection assay in two DDX3 downregulated HeLa stable cell lines. Figure 2d indicates an increase in capdependent RLuc translation (140-146% of the control) in DDX3 downregulated cells and also shows essentially no effect on IRES-mediated FLuc translation (101-107% of the control). Therefore, our results clearly indicate that downregulation of DDX3 preferentially enhances cap-dependent translation, a feature in agreement with the suppressive role of DDX3 on capdependent translation.
The DDX3-mediated preferential suppression of capdependent translation but not IRES-mediated translation infers a possible regulatory function for DDX3 in translation initiation. To examine this notion, polysome profiles of 293T cells transfected with the FLAG-DDX3 expression construct or empty vector were analysed. As shown in Figure 3 , overexpression of DDX3 resulted in a decrease in polysomal content and a significant increase in 80S monosome peak, which indicates a defect in translation initiation. Thus, polysome profiles analysis suggests that DDX3 acts as a translation initiation regulator.
DDX3 is an eIF4E-binding protein
To explore the underlying mechanisms of DDX3-mediated translation regulation, we investigated the interaction between DDX3 and several translation initiation factors using GST pull-down assays. Figure 4a demonstrated that GST-DDX3 pulled down eIF4E (lane 2), but GST did not (lane 1). In addition, RNase A treatment of cell lysates had no effect on this association (lane 4). These results indicate that DDX3 associates with eIF4E in vitro and that this interaction is not RNA-dependent. Next, we examined whether DDX3 interacts directly with eIF4E using bacterially expressed fusion proteins. As shown in Figure 4b , His-DDX3 was retained on the GST-eIF4E bound-affinity beads (lane 7), but not on the GST control resins or on affinity beads alone (lanes 5 and 6), indicating a direct interaction between DDX3 and eIF4E.
To further examine the molecular interaction between DDX3 and eIF4E in vivo, HeLa cell lysates were supplemented with RNase A and subjected to immunoprecipitation with anti-eIF4E antibody-conjugated resins. Figure 4c showed that DDX3 together with eIF4E were immunoprecipitated by anti-eIF4E antibody (lane 2) but not by control serum (lane 1). In a reciprocal experiment, anti-DDX3 antibody precipitated eIF4E ( Figure 4c , lane 5). Taken together, these results indicate that DDX3 and eIF4E forms a specific complex both in vitro and in vivo.
DDX3 interacts with the dorsal surface of eIF4E through the conserved eIF4E-binding sequence Next, we further defined the interaction regions of DDX3 with eIF4E by GST pull-down assay. DDX3 is characterized by a core segment of several spaced DEAD-box family conserved functional motifs (Rocak and Linder, 2004) . As shown in Figure 5a , although the conserved core segment (DDX3 ) did not interact with eIF4E (lane 4), the N-terminal region (DDX3 ) showed a positive interaction (lane 3). The C-terminal domain (DDX3 ) also interacted with eIF4E but the binding was much weaker (lane 5). Additionally, both DDX3
1-100 and DDX3 1-226 could pull down eIF4E ( Figure 5a , lanes 2 and 3), suggesting that the N-terminal 100 amino-acid fragment of DDX3 is sufficient to bind eIF4E. 293T cells were transfected with vector or pcDNA-SRa/FLAG-DDX3. The distribution of ribosomes was determined by sedimentation through 15-50% sucrose gradients. UV absorbance tracings (optical density at 254 nm) for these gradients are shown and monitor the location of ribosomal complexes. The ribosome subunits (40S and 60S), the 80S monosome and the polysome peaks are indicated. Western blot analysis of transfected cell lysates (50 mg) for the expression of FLAG-DDX3 is shown at the bottom. All these results are representative of at least three separate experiments. UV, ultraviolet.
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It has been reported that several eIF4E-binding proteins recognize eIF4E via a consensus YxxxxLF motif (reviewed by Sachs and Varani, 2000; von der Haar et al., 2004; Richter and Sonenberg, 2005) . Careful inspection of the eIF4E-binding region within DDX3 identifies a potential eIF4E-binding motif (YIPPHLR) at amino-acid residues 38-44 (Figures 5b and c) . To determine whether this putative eIF4E-binding consensus is functional, we analysed the interaction of eIF4E with point mutants of DDX3, in which the conserved Tyr 38 or Leu 43 residue was replaced with Ala. Figure 5d showed that these two mutations impaired the DDX3-eIF4E interaction (compare lane 8 with lanes 6 and 7), suggesting that DDX3 interacts with eIF4E through this conserved eIF4E-binding motif.
Next, we examined whether the eIF4E-binding motif directly interacts with a conserved Trp 73 within the dorsal surface of eIF4E as occurs with other eIF4E-binding partners (von der Haar et al., 2004) . Consistent with previous findings, our GST pull-down results (Figure 5e ) showed that a mutation at Trp 73 of eIF4E impaired its interaction with DDX3 (compare lane 5 with lane 6). Together, these results indicate that DDX3 utilizes a consensus eIF4E-binding motif to directly interact with the functionally important dorsal surface of eIF4E in the similar manner to other eIF4E-binding proteins. Notably, this sequence is highly conserved among DDX3 homologues (Figure 5c ), suggesting that it has functional importance.
The DDX3-eIF4E interaction is required for the DDX3-mediated regulatory effect on translation To address the role of DDX3-eIF4E interaction in the DDX3-mediated translation regulation, in vitro translation assays were carried out with purified GST-DDX3 or its eIF4E-binding defective mutants (GST-DDX3   Y38A and GST-DDX3 L43A ). As shown in Figure 6a , wild-type DDX3 led to 70% reduction in cap-dependent translation, whereas its point mutants exerted a less severe repression. Notably, GST-DDX3 Y38A resulted in a more severe reduction in cap-dependent translation than did DDX3 interacts with translation factor eIF4E. (a) DDX3 associates with eIF4E in vitro. Purified GST or GST-DDX3 proteins (5 mg) were coupled to glutathione-sepharose beads (20 ml). GST-pull-down assays were performed by incubation of purified GST fusion proteins with HuH-7 cell extracts (500 mg) with or without RNase treatment. Proteins retained on beads were analysed by immunoblotting with anti-eIF4E antibody (BD Transduction Laboratories). (b) DDX3 interacts with eIF4E directly. Purified GST, GST-eIF4E and His-DDX3 were analysed by SDS-PAGE and stained with Coomassie brilliant blue (CB). His-DDX3 proteins (5 mg) were incubated with GST fusion proteins (5 mg) prebound on the glutathione-sepharose resins (20 ml). After extensive wash, proteins retained on the beads were analysed by immunoblotting with DDX3 antisera. (c) DDX3 interacts with eIF4E in vivo. HeLa cell lysates (1 mg) were incubated with 20 ml of protein G-sepharose beads conjugated with rabbit anti-eIF4E antiserum, rabbit anti-DDX3 antiserum or control sera at 41C. After 2 h, beads were washed, boiled with sampling buffer and analysed by immunoblotting. GST, glutathione-S-transferase; eIF4E, eukaryotic initiation factor 4E; SDS-PAGE, sodium dodecyl sulfate-polacrylamide gel electrophoresis.
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L43A (42 versus 18%), which correlates with their relative binding ability to eIF4E (Figure 5d , lanes 6 and 7). Interestingly, a decrease in IRES-mediated translation was noted for these eIF4E-binding defective mutants as compared to the wild-type GST-DDX3 (81-83 versus 110%).
We further addressed the role of DDX3-eIF4E interaction in the DDX3-mediated translation regulation in vivo using the bicistronic reporter and the eIF4E-binding defective mutants of DDX3. As shown in Figure 6b and consistent with the previous results (Figure 2c , lanes 1 and 2), overexpression of wild-type DDX3 led to a differential regulation of cap-and IRES-dependent translation. Specifically, there was a suppression of cap-dependent RLuc translation (69% reduction, lane 2, Figure 6b ) and an enhancement of IRES-mediated FLuc translation (83% increase, lane 2). Moreover, in agreement with the in vitro experiments (Figure 6a ), inhibition of cap-dependent translation by DDX3 required interaction with eIF4E, because a partial loss of the eIF4E-DDX3 interaction in these two DDX3 mutants severely impaired the inhibitory effect of DDX3 on the translation of capped RNAs in vivo (Figure 6b, lanes 3 and 4) . Furthermore, these eIF4E-binding defective DDX3 mutants also lost their ability to enhance IRES-mediated translation (compare lanes 2-4), suggesting that the eIF4E-DDX3 interaction is a prerequisite for DDX3-mediated activation effect on cap-independent translation. Together, these results indicate that the DDX3-eIF4E interaction is required for the DDX3-mediated regulatory effect on translation.
DDX3 enhances the cap-binding ability of eIF4E As DDX3 interacts with the dorsal region of eIF4E that mediates cap-binding affinity, we next examined whether DDX3 acts as a modifier of cap binding to suppress translation. To this end, we performed m 7 GTP-sepharose cap affinity chromatography with the purified GSTeIF4E and His-DDX3 recombinant proteins. As shown in Figure 7a , addition of His-DDX3 was found to greatly enhance the amount of eIF4E retained on the m 1-4) . The abilities of DDX3 mutants to bind wild-type eIF4E were monitored by immunoblotting in the lower panel (lanes 5-8). (e) The conserved W73 residue within eIF4E is critical for the interaction with DDX3. GST (10 mg), GST-eIF4E and GST-eIF4E W73A (5 mg each) prebound to glutathione-sepharose beads (20 ml) (lanes 1-3) were incubated with 5 mg of purified His-tagged DDX3. Lanes 1-3 demonstrated the loading of the bait GST fusion proteins. After extensive washing, DDX3 retained on the beads were analysed by immunoblotting (lanes 4-6) . eIF4E, eukaryotic initiation factor 4E; GST, glutathione-S-transferase. GTP-sepharose is mediated by eIF4E. Next, we examined whether DDX3-mediated enrichment of the cap-binding eIF4E-DDX3 complex also occurs in cellular context of DDX3-overexpressing cells. As shown in Figure 7c , forced expression of FLAG-DDX3 increased the amount of eIF4E binding to the cap analog (lanes 2-4 in upper panel). These effects occurred in parallel with the increasing amount of FLAG-DDX3. However, as the eIF4E protein level was not altered by ectopic expression of FLAG-DDX3 (Figure 7c , lanes 6-8 in lower panel), the enhancement of eIF4E bound with the cap analog cannot be ascribed to a change in the cellular eIF4E level. Moreover, the amount of DDX3 captured by the m 7 GTP-sepharose was clearly increased in the presence of exogenous FLAG-DDX3 (lanes 2-4 in lower panel), suggesting that DDX3 could compete with other eIF4E-binding proteins for binding to the dorsal region of eIF4E.
DDX3 blocks eIF4E-eIF4G complex formation
The eIF4E inhibitory proteins harboring the eIF4E-binding consensus are mutually exclusive for binding to eIF4E and block translation initiation by competing with eIF4G for eIF4E binding (reviewed in von der Haar et al., 2004; Richter and Sonenberg, 2005) . In view of this, we further investigated whether DDX3 disrupts the eIF4E-eIF4G complex by a competition assay. HeLa cell lysates were preincubated with purified Histagged DDX3 before the addition of m 7 GTP-sepharose beads and the protein complex retained on the beads was analysed by immunoblotting. As shown in Figure 8a , increasing amounts (1-5 mg) of His-DDX3 efficiently blocked the binding of eIF4G to eIF4E in a dose-dependent manner, demonstrating that DDX3 and eIF4G compete for binding to eIF4E.
Next, we examined whether the eIF4E-binding ability of DDX3 affects the competition between DDX3 and eIF4G for eIF4E-binding. To this end, wild-type or eIF4E-binding defective mutants of DDX3 expression Putative eIF4E-binding motif
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HGDRSQRDRE EALHQFRSGK SPILVATAVA ARGLDISNVK HVINFDLPSD IEEYVHRIGR TGRVGNLGLA TSFFNERNIN ITKDLLDLLV EAKQEVPSWL EN-MAYEHHY KGSSR-----------------------GR SKSSRFSGGF 597 mDDX3 HGDRSQRDRE EALHQFRSGK SPILVATAVA ARGLDISNVK HVINFDLPSD IEEYVHRIGR TGRVGNLGLA TSFFNERNIN ITKDLLDLLV EAKQEVPSWL EN-MAFEHHY KGSSR-----------------------GR SKSSRFSGGF 597 An3 513 HGDRSQRDRE EALHQFRSGK SPILVATAVA ARGLDISNVK HVINFDLPSD IEEYVHRIGR TGRVGNLGLA TSFFNEKNIN ITKDLLDLLV EAKQEVPSWL EN-MAYEQHH KSSSR-----------------------GR SKS-RFSGGF 637 Bel 590 HGDRTQKERE EALRCFRSGD CPILVATAVA ARGLDIPHVK HVINFDLPSD VEEYVHRIGR TGRMGNLGVA TSFFNEKNRN ICSDLLELLI ETKQEIPSFM ED-MSSDRGH GGAKRA----------------------GR GGGGRYGGGF 716 Ded1 430 HGDRTQSERE RALAAFRSGA ATLLVATAVA ARGLDIPNVT HVINYDLPSD VDDYVHRIGR TGRAGNTGLA TAFFNSENSN IVKGLHEILT EANQEVPSFL KDAMMSAPGS RSNSR------------------------R GGFGRNNN--553 p68 372 HGDKSQQERD WVLNEFKHGK APILIATDVA SRGLDVEDVK FVINYDYPNS SEDYIHRIGR TARSTKTGTA YTFFTPNNIK QVSDLISVLR EANQAINPKL LQLVEDRGSG RSR GRGGMKD DRRDRYSAGK RGGFNTF RDR ENYDRGYSSL 521
Motif V Motif VI
DDX3
GARDYRQSSG ASSSSFSSSR ASSSRSGGGG HGSSR----------GFGGG GYGGFYNSDG YGGNYN-------SQGVDWW GN----------------662 mDDX3 GARDYRQSSG ASSSSFSSSR ASSSRSGGGG HGGSR----------GFGGG GYGGFYNSDG YGGNYN-------SQGVDWW GN----------------662
Bel
GSRDYRQSSG GGGGGRSGPP PRSGGSGSGG GGGSYRSNGN SYGGN SGGGG YYGGGAGGGS YGGSYGGGSA SHSSNAPDWW AQ----------------798 Ded1 553 --RDYRKAGG ASAGGWGSSR SRDN--------SFR------------GGS GWGSDSKSSG WGNSGG-------SNNSSWW ------------------604 p68 522 LKRDFGAKTQ NGVYSAANYT NGSFGSNFVS AGIQTSFRTG -----NP TGT YQNGYDSTQQ YGSNVPNMHN GMNQQAYAYP ATAAAPMIGY PMPTGYSQ 6 14
An3
GAKDYRQSSG AG-SSFGSSR GGRS----SG HGGSR----------GFGGG -YGGFYNSDG YGGNYGG------SSQVDWW GN----------------697
Figure 5 Continued.
DDX3 interacts with eIF4E and regulates translation J-W Shih et al plasmids were transfected into 293T cells and the cell extracts were analysed by m 7 GTP-sepharose chromatography. Figure 8b revealed a similar expression level for all ectopic FLAG-DDX3 and endogenous eIF4E and eIF4G (lower panel). Nevertheless, exogenous wild-type FLAG-DDX3 effectively interacted with eIF4E and associated with the cap-binding complex (Figure 8b , lane 2), whereas its eIF4E-binding defective mutant (FLAG-DDX3 Y38A and FLAG-DDX3 L43A ) failed to bind the cap-binding complex (lanes 3 and 4), most likely due to their impaired interaction with eIF4E. In addition, exogenous wild-type FLAG-DDX3 slightly enriched the amount of eIF4E bound to the cap, as noted previously (Figure 7c ). In contrast, no significant effect on the cap binding of eIF4E was found when FLAG-DDX3 Y38A and FLAG-DDX3 L43A were overexpressed. Moreover, wild-type FLAG-DDX3 substantially blocked the binding of eIF4G to eIF4E, whereas competition between mutant FLAG-DDX3 proteins and eIF4G was less effective. These results further support the notion that DDX3 inhibits cap-dependent translation through blockage of eIF4E-eIF4G complex formation.
The DDX3-eIF4E interaction is required for the tumor growth suppressive ability of DDX3 Our previous studies have demonstrated that the DDX3-mediated upregulation of p21 waf1/cip1 promoter activity could account for the tumor suppressor function of DDX3 (Chang et al., 2006; Chao et al., 2006) . Based on this, we extended our studies to address whether the DDX3-eIF4E interaction is required for the aforementioned property of DDX3. Cell growth was evaluated by a colony formation assay as described previously (Chao et al., 2006) . As shown in Figure 9 , ectopic expression of FLAG-DDX3 inhibited the colony formation activity (4-6% of the control), which is consistent with our previous report (Chao et al., 2006) . However, a substantial increase in foci formation (20-46% of the control) was observed in cells overexpressing eIF4E-binding defective DDX3 mutants (DDX3   Y38A   and  DDX3   L43A ) as compared to the wild-type DDX3. This indicates that an impaired interaction between DDX3 and eIF4E reduces the ability of DDX3 to repress cell growth. Notably, DDX3 DQAD mutant also partially lost the suppressive ability on cell growth (38% of the control) as compared to the wild-type DDX3 (Figure 9 , left panel), possibly due to its defect in transactivation ability on p21 waf1/cip1 promoter (Chao et al., 2006) . Most interestingly, the double mutation of the DEAD box and the eIF4E-binding motif in DDX3 DQAD/L43A mutant led to a nearly complete loss (88% of the control) of the growth-suppressive capability of DDX3 (Figure 9 , right panel). Taken together, these results indicate that the DDX3-eIF4E interaction is required for the tumor suppressor function of DDX3. Thus, in addition to the transactivation ability on p21 waf1/cip1 promoter, the DDX3-mediated translational regulation could also account for its tumor suppressor function.
Discussion
DEAD-box RNA helicase DDX3 participates in disparate cellular processes (see Introduction). In this work, we described a new role for DDX3 in translation regulation. We demonstrated that DDX3 is capable of inhibiting global protein synthesis (Figure 1) . Using a bicistronic RNA reporter, the results presented here The DDX3-eIF4E interaction is required for the DDX3-mediated differential regulatory effect on cap-and IRES-dependent translation in vivo. 293T cells were transfected with 2 mg of parental vector, FLAG-DDX3 or FLAG-DDX3 mutants. The cells were then transfected with RNA reporter, harvested and assayed for the luciferase activity as described above. The luciferase activity of vector only transfected cells is designated as 100%. Each experiment was performed in triplicate and error bars represent the s.d. of the mean. Western blot analysis of the transfected cell lysates (50 mg) for the expression of exogenous DDX3 (including mutants) is shown at the bottom. eIF4E, eukaryotic initiation factor 4E; GST, glutathione-S-transferase; IRES, internal ribosomal entry site.
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reveal that DDX3 specifically inhibits cap-dependent translation but not IRES-mediated translation (Figure 2 ). Polysome profile analysis further suggests that the translation initiation process is the primary target for DDX3 (Figure 3) . Interestingly, DDX3 physically interacts with the cap-binding translation factor eIF4E (Figure 4 ) and contains a consensus eIF4E-binding motif (Figures 5b and c) . This consensus eIF4E-binding sequence is shown here to be required for eIF4E-binding and DDX3-mediated translational regulation (Figures 5d and 6 ). It should also be noted that both DDX3 and translation adaptor eIF4G bind to the same region of eIF4E (Figure 5e ). Most importantly, we demonstrate two mechanistic features of DDX3-induced suppression on the cap-dependent translation, namely a cooperative enhancement of eIF4E retained on the cap ( Figure 7 ) and a blockage of the binding of eIF4G to eIF4E (Figure 8 ). All these features together indicate that DDX3 RNA helicase acts as a new member of the eIF4E inhibitory proteins. To our knowledge, this is the first report of RNA helicase functioning as an eIF4E inhibitory protein.
Although DDX3 harbors RNA helicase activity, which could presumably itself have some effect on translation, our results reveal that the protein's RNA unwinding activity is not required for the DDX3-mediated suppression of cap-dependent translation in vivo (Figure 2c) . The most unique feature of DDX3, which might reflect on its regulatory role in translation, is the presence of a functional eIF4E-binding motif within DDX3 molecule (Figures 5b and c) . This YIPPHLR motif is located within the N-terminal region of DDX3, which is generally divergent among DEAD box RNA helicases. However, as shown in the protein sequence alignment, this eIF4E-binding motif is strikingly well conserved in the various DDX3 homologues, but is absent in other DEAD box proteins such as p68 (Figure 5c ). In the view of the fact that these proteins have been implicated in regulatory processes of development and cell growth, it will be of interest to assess the functional roles of these putative eIF4E-binding regions within other Ded1p subfamily proteins. It should be noted that this eIF4E-binding motif contains a non-consensus charged arginine residue in the last position instead of a hydrophobic one (Figure 5b ), which could result in relatively weak binding. This finding may reflect the requirement for an additional specific interaction of DDX3 with mRNA to support the effective DDX3-eIF4E interaction as is the case with several eIF4E-binding proteins (Richter and Sonenberg, 2005) . Alternatively, but not exclusively, the weak interaction between eIF4E and the C-terminus of DDX3 characterized here (Figure 5a ) may contribute to enhancing this interaction. Identification of the additional components of this complex will provide further insight into the regulatory mechanism underlying DDX3-mediated translational modulation. It should also be noted that DDX3 has been proposed to be required for translation initiation based on a genetic complementation study of the homologue ded1 deletion in yeast (Mamiya and Worman, 1999) , which differs from our findings. The exact reason for this discrepancy is unclear. However, apart from translation, both Ded1p and DDX3 have been linked to transcription, splicing, ribosome biogenesis and nuclear transport (reviewed by Linder, 2003) . Thus, the lethality of the ded1 deletion GTP-sepharose binding assays were performed essentially as described in the legend of (a) except that some assays were performed in the absence of GST-eIF4E. (c) Overexpression of DDX3 enhances the binding of eIF4E to cap analog. HeLa cells (2 Â 10 5 ) were transfected with various amounts of FLAG-DDX3 expression plasmid as indicated. Cell lysates (50 mg) prepared at 48 h post-transfection were analysed by immunoblotting using antibodies against FLAG, eIF4E and tubulin (Abcam) (lanes 5-8 in lower panel). Approximately 500 mg of transfected cell lysates were applied to each m 7 GTP-sepharose affinity assay. The bound proteins were analysed by immunoblotting (lanes 1-4 in upper panel). These results are representative of three separate experiments. eIF4E, eukaryotic initiation factor 4E; GST, glutathione-S-transferase. mutant and the ability to rescue the phenotype may result from defects and complementation effects involving cellular functions other than translation. Alternatively, the discrepancies between the effects exerted by Ded1p and DDX3 on translation may reflect the different translation systems in two species.
Although cap-dependent translation represents the standard mode of translation for most cellular mRNAs, translation of several cellular stress-response genes and a subset of viral RNAs are initiated in a cap-independent manner (Hellen and Sarnow, 2001) . In this report, we utilized a bicistronic reporter to demonstrate the DDX3-mediated inhibitory effect on cap-dependent translation in both in vivo and in vitro assay systems. Interestingly, DDX3 stimulates IRES-mediated translation in vivo (Figures 2 and 6 ). Such in vivo stimulation of IRESmediated translation has been observed with 4EBP3 (Poulin et al., 1998) but not with 4EBP1 or 4EBP2 (Pause et al., 1994; Ohlmann et al., 1996) . Furthermore, the eIF4E-binding defective DDX3 mutants, but not the helicase-or ATPase-defective mutants, lost their capacity to stimulate HCV IRES-mediated translation ( Figures 2c and 6b) ; this suggests that the DDX3-eIF4E interaction is a priming event for the stimulation of IRES-mediated translation. The availability of functional eIF4E has been shown to be a switch between cap-dependent and cap-independent translation (Svitkin et al., 2005) . Along this line, sequestration of eIF4E by DDX3 would free other initiation factors (eIFs) shared by the capped-and IRES-containing mRNAs and thereby favors IRES-mediated translation. Conceivably, our study implies that through sequestration of the availability of eIF4E, DDX3 may augment HCV viral replication or selectively stimulate IRES-directed translation of stress-response genes.
eIF4E plays a central role in gene expression control and thereby affects development, cell-cycle progression, metabolism and tumorigenesis (Richter and Sonenberg, 2005) . It has been reported that a group of cellular factors, the eIF4E inhibitory proteins, including the 4E-BPs, eIF4E transporter (4E-T), Cup, Maskin and Bicoid, are able to control translation initiation by modulating the eIF4E-eIF4G interaction through the eIF4E-binding motif (for recent reviews, see von der Haar et al., 2004; Richter and Sonenberg, 2005) . Despite their intriguing similarities, the cellular localization, tissue distribution, substrate specificity and signaling control of these eIF4E inhibitory proteins are quite distinct as is their unique regulatory roles in the different processes. For example, the 4E-BPs inhibit the majority of mRNA translation in a reversible manner in response to various signals, while several other eIF4E inhibitory proteins (Cup, Maskin and Bicoid) suppress translation in a transcript-specific manner at the early stages of development (Richter and Sonenberg, 2005) . Furthermore, the interaction between 4E-T and eIF4E has been implicated in targeting mRNPs (messenger RNA and protein) to mammalian processing bodies and mRNA decay (Andrei et al., 2005; Ferraiuolo et al., 2005) . In our case, taking into account that the ectopic expression of DDX3 results in a general inhibition of de novo 4 in upper panel) . These results are representative of three separate experiments. eIF4E, eukaryotic initiation factor 4E.
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J-W Shih et al protein synthesis (Figure 1 ), it appears that DDX3 represses cellular translation globally like the 4E-BPs. Moreover, when considering that DDX3 is the first RNA helicase reported to be an eIF4E inhibitory protein and that the protein has been isolated from a range of cellular compartment including RNA-transporting granules, splicesomes, the nucleus and the cytoplasm (Zhou et al., 2002; Kanai et al., 2004; Yedavalli et al., 2004) , DDX3 may impart pleiotropic effects on cellular functions through its interaction with eIF4E. Specifically, we suggest that DDX3 may mediate translational silencing of capped mRNAs during transport. Additionally, the DDX3-mediated stimulation of IRES-dependent translation, as reported in this work, suggests that it may be involved in the cell's stress response. Presumably, the biological roles of DDX3 may overlap with other eIF4E-binding proteins to provide a backup or compensatory mechanism. As shown in our recent work, DDX3 exerts an inhibitory effect on cell growth, whereas a genetic knockdown of DDX3 results in an enhancement of cell proliferation (Chang et al., 2006; Chao et al., 2006) . This cell growth-suppressive property of DDX3 is linked to its transactivation ability on p21 waf1/cip1 promoter through physical interaction with Sp1 (Chao et al., 2006) . Furthermore, a significant downregulation of DDX3 expression has been observed in hepatoma specimens (Chang et al., 2006; Chao et al., 2006) . All these features suggest that DDX3 acts as a tumor suppressor. In this report, we further demonstrate that the DDX3-mediated translation regulation is required for the growthsuppressive property of DDX3 (Figure 9 ).
The most significant result obtained from the present study is that, in addition to acting as a transcriptional regulator, DDX3 also affects translation through suppressing eIF4E activity. It should be stressed here that, apart from its central role in translation control, eIF4E is essential for cell survival and is involved in neoplastic transformation (reviewed by Mamane et al., 2004) . Moderate overexpression of eIF4E has been shown to result in deregulated cell proliferation and malignant transformation (reviewed by De Benedetti and Graff, 2004) . Moreover, high levels of eIF4E are characteristic of many human tumors (De Benedetti and Graff, 2004) . These growth-promoting properties of eIF4E are mainly due to the increased translation rates of several growth-critical eIF4E-sensitive mRNAs that have a specific requirement for eIF4E activity (De Benedetti and Graff, 2004) . In contrast, sequestration of eIF4E levels can reverse the transformed phenotype. Conceivably, the eIF4E inhibitory protein 4E-BP1 has been reported to act as a tumor suppressor gene product (Rousseau et al., 1996; Lynch et al., 2004) . Notably, many other tumor suppressors, such as p53 and Pdcd4 (programmed cell death 4), also exert their growth inhibitory effect by modulation of translation initiation in addition to their roles as a transcriptional regulator (Horton et al., 2002; Yang et al., 2003) . Thus, as with the case of p53, translational regulation should therefore be added to the various mechanisms, including , FLAG-DDX3 DQAD and FLAG-DDX3 L43A/DQAD expression plasmid by the Effectene Transfection Reagent. The transfected cells were then applied for the colony formation assay (see Materials and methods). Expression levels of exogenous DDX3 were examined by immunoblotting. In all cases, the number of foci is relative to the vector control, which was assigned as 100%. Results were derived from three independent experiments performed in triplicate and error bars indicate71 s.d.
transcriptional upregulation of p21 waf1/cip1 gene, by which DDX3 exerts its growth-suppressive effects. Furthermore, since DDX3-associated eIF4E has a multitude of cellular functions (Strudwick and Borden, 2002) , presumably their complex formation may also impart on DDX3 a capability of regulating these functions as well. In conclusion, this work characterizes a RNA helicase, DDX3, as a new member of eIF4E inhibitory protein family and provides a mechanistic and molecular framework for understanding the functional roles of DDX3 in translation regulation, cell growth control and likely viral replication.
Materials and methods
Cell culture and transfection
Human hepatocellular carcinoma HuH-7, human embryonic kidney fibroblast 293T and human cervical cancer cells HeLa cell lines were cultured in Dubecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Invitrogen-Life Technologies, Carlsbad, CA, USA) under 5% CO 2 at 371C. Two DDX3-knockdown stable HeLa cell lines, designated siDDX3-433-11 and siDDX3-433-13, as well as a control cell line, were established using the small interfering RNA containing plasmid psiDDX3-433 or the control plasmid pSuper as described previously (Chang et al., 2006) . For transient transfection, unless otherwise noted, cells were transfected with appropriate amounts of plasmid DNA by the calcium phosphate method.
Plasmids and recombinant proteins
Plasmids pcDNA-SRa/FLAG, pcDNA-SRa/FLAG-DDX3, pcDNA-SRa/FLAG-DDX3(AAA) and pcDNA-SRa/FLAG-DDX3(DQAD) have been described previously (Chao et al., 2006) . To express GST-4EBP1, GST-DDX3 or GST-eIF4E deletion variants, the PCR-generated DNA fragments containing the indicated coding region of 4EBP1, DDX3 or eIF4E were cloned into the EcoRI and XhoI sites of pGEX-5x-1 plasmid (Amersham Pharmacia Biotech, Buckinghamshire, UK). Point mutations were engineered using a QuikChange XL site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). Plasmid pWP2, which directs the expression of the bicistronic luciferase transcript, was kindly provided by Dr Mei-Ru Chen (National Taiwan University, Taipei, Taiwan). Briefly, this plasmid, which is derived from the pRL-CMV vector (Promega, Madison, WI, USA), contains the CMV and T7 promoters for transcription, the RLuc gene, followed by the HCV IRES (nt 1-371) and the FLuc gene from the pUC18-M371-Luc plasmid (Hwang et al., 1998) . Plasmids pET28a/ EGFP, which directs the expression of the EGFP transcript, was constructed by insertion of a 0.8-kb NheI/EcoRI fragment from pEGFP-C2 (BD Biosciences Clontech, Palo Alto, CA, USA) into pET-28a vector (Novagen, Madison, WI, USA). The integrity of each construct was verified by nucleotide sequencing. GST fusion proteins and His-tagged DDX3 were purified as described previously (You et al., 1999; Kao et al., 2004) .
Metabolic labeling and determination of amino-acid incorporation rates 293T cells (2 Â 10 5 ) were transfected with pcDNA-SRa/FLAG-DDX3 or parental vector (0.5-2 mg). At 24 h post-transfection, equal numbers of transfected cells underwent [
35 S]methionine metabolic labeling as described previously (Horton et al., 2002) . Determination of the amino-acid incorporation rates in the different DDX3-knockdown stable HeLa cell lines was performed similarly.
Synthesis of mRNA transcripts
For the production of capped bicistronic luciferase or EGFP transcripts, BamHI-treated pWP2 plasmid or EcoRI-treated pET28a/EGFP plasmid were transcribed and capped in vitro using a mMESSAGE mMACHINE T7 Kit (Ambion, Austin, TX, USA) followed by polyadenylation using a poly(A) Tailing kit (Ambion). The quality and quantity of the RNAs were checked by agarose gel electrophoresis and optical density measurement. RNA samples were stored in small aliquots at À801C.
In vitro translation
Capped bicistronic RNA transcripts were translated in the rabbit reticulocyte lysates system (RRL; Promega). Before addition of mRNA, the lysates were preincubated with either control buffer or GST (or a GST fusion) for 10 min. In vitro translation was then conducted in 12.5 ml mixture at 301C for 90 min as recommended by the manufacturer. Aliquots of the translation reaction were measured enzymatically using the luciferase assay.
DNA/RNA transfection and reporter assay 293T cells (2 Â 10 5 ) were transfected with empty parental vector or DDX3 expression construct using SuperFect reagents (Qiagen, Hilden, Germany). At 3 h post-transfection, the cells were washed and incubated for another 6 h and were then transfected with 4 mg of purified bicistronic luciferase RNA reporter using cationic liposomes reagent DMRIE-C (Invitrogen-Life Technologies). After overnight incubation, cells were harvested and a dual luciferase assay was performed according to the manufacturer's instructions (Promega).
For determining the cap-dependent and cap-independent translation efficiency in DDX3-knockdown stable HeLa cell lines (siDDX3-433-11 and siDDX3-433-13), each cell line was co-transfected with 4 mg of bicistronic luciferase RNA reporter and 1 mg of EGFP RNA reporter as described above. The luciferase activity was assayed and normalized with the transfection efficiency of the co-transfected EGFP RNA reporter as estimated by fluorescence microscopic observation.
Polysomal fractionation and analysis 293T cells were transfected with pcDNA-SRa/FLAG-DDX3 or parental vector and were then treated with 0.2 mM cycloheximide for 15 min at 48 h post-transfection. Cell lysates were loaded on 12-ml 15-50% sucrose density gradients and sedimented for 3 h at 35 000 r.p.m. in a Beckman SW41-Ti rotor at 41C. The gradient was collected in fractions with continuous ultraviolet (UV) monitoring at 254 nm.
GST pull-down assay About 20 ml of glutathione-sepharose resin prebound with GST (10-15 mg) or GST fusion proteins (5 mg) were mixed with 1 mg of cell protein extracts or 5 mg of His-tagged purified DDX3 protein in phosphate-buffered saline containing 0.5% NP-40 and incubated at 41C for at least 3 h with continuous agitation. The resins were then harvested, extensively washed and analysed by immunoblotting.
In vivo co-immunoprecipitation Whole lysates of HeLa cells were prepared as described previously (Kao et al., 2004) . The cell extracts (1 mg) were then mixed with 20 mg of rabbit anti-eIF4E antiserum (Abcam, Cambridge, UK), rabbit anti-DDX3 antiserum (Chao et al., 2006) or preimmune rabbit serum and incubated with 20 ml of protein G beads for 2 h at 41C. The beads were extensively washed and analysed by immunoblotting using specific antibodies against DDX3 (Chao et al., 2006) or eIF4E (BD Transduction Laboratories, Lexington, KY, USA).
Analytical m
7 GTP-sepharose chromatography GST-eIF4E (5 mg) and His-DDX3 (1-5 mg) were incubated together in cap-binding buffer (20 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid pH 7.4, 100 mM KCl, 1 mM dithiothreitol and 2 mM MgCl 2 ) at 41C for 10 min, then 30 ml of m 7 GTP-sepharose resin (Amersham Pharmacia Biotech) were added and the total volume was made up to 500 ml with capbinding buffer. After incubation on a shaker at 41C for 30 min, the resin was then washed three times with cap-binding buffer and aliquots of the resin were analysed by immunoblotting. Protein competition assays were performed essentially as described earlier (Niessing et al., 2002) .
Colony formation assay
HuH-7 cells (3 Â 10 5 cells/60 mm per plate) were transfected with 0.4 mg of pcDNA-SRa/FLAG-DDX3, its point mutants or its parental empty vector DNA by Effectene Transfection Reagent (Qiagen). The colony formation assay was performed as described previously (Chao et al., 2006) .
